DSIP should be approached with particular caution by individuals with severe psychiatric conditions, untreated sleep disorders like severe sleep apnea, or those taking medications affecting the central nervous system
Clinical studies show that patients who discontinue semaglutide typically regain approximately two-thirds of their lost weight within one year of stopping treatment
Additionally, if side effects prevent you from eating adequate nutrition or cause significant distress beyond the first two weeks of adjustment, a dose adjustment or medication review may be necessary
however, access often depends on your insurance coverage
GLP-1 receptor agonists represent a transformative advancement in the fight against obesity, a growing global health crisis
210 With a growing prevalence of obesity and overweight in Australia, expediting mechanisms to improve access to multidisciplinary obesity care is critical